• Blog
  • Diabetes Injection Pens Market Analysis | 2023-2028

    Diabetes Injection Pens Market Analysis | 2023-2028

    Diabetes Injection Pens Market Analysis | 2023-2028
    Report code - SR1767 Delivery - 2 Weeks
    Diabetes Injection Pens Market Size, Share, Trends, Forecast & Industry Anal See more...

    “The Diabetes Injection Pens Market was estimated at US$ 3.27 billion in 2022 and is expected to grow at a healthy CAGR of 10.8% during 2023-2028 to reach US$ 6.07 billion by 2028.”

    Diabetes Injection Pens Market Size

    Wish to get a Free Sample? Register Here

    Market Dynamics

    Introduction

    Diabetic patients use diabetes injection pens to regulate insulin. It is an easy & convenient way of taking insulin doses via an injection. Diabetes injection pen aids in enhancing the quality of life and minimizes fear of hyperglycemia. The lower cost of insulin pens spurs their affordability among the different age groups of people. Diabetes pens should not be shared among others as there is a risk of transmission of diseases such as hepatitis B

    Diabetes Injection Pens Market Report Overview

    Market Size in 2028

    USD 6.07 Billion

    Market Size in 2022

    USD 3.27 Billion

    Market Growth (2023-2028)

    CAGR of 10.80%

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Market Drivers

    The market is driven by the following hosts of factors, some of which are given below:

    • The market is primarily propelled by the rising prevalence of diabetes.

    • Strong technological developments and new product innovation concerning the needle length further offer significant growth potential. 

    • Diabetes pen needles with shorter lengths can be easily used by every patient including overweight patients.

    • Moreover, simple functioning & accuracy related to insulin dosing further bolsters the industry growth during the forecast timeline.

    Diabetes Injection Pens Market Snapshot

    To Get the full scope of the report Register Here

    COVID-19 Impact

    The outbreak of COVID-19 moderately affected the diabetes injection pens industry. The supply chain for injection pens was disrupted due to closed borders, transport restrictions, and a decline in overall trade. The COVID-19-infected patients who received treatment are at a higher risk of becoming diabetic. Thus, rising incidences of diabetes are likely to spur the demand for injection pens, amid the pandemic

    Segments Analysis

    Usage Trends

    The market has been classified into reusable injection pens and disposable injection pens. The reusable injection pens segment accounted for the largest market share in 2022 & is expected to remain the largest market during the forecast period.

    This is mainly attributed to increasing demand from diabetic patients, growing awareness regarding the self-administration of insulin, and its cost-effective nature in comparison to disposable injection pens.

    Regional Analysis

    North America accounted for the highest market share in 2022 and is expected to grow at a robust CAGR during the review period.

    The market growth is mainly attributed to favorable reimbursement scenarios, the surging prevalence of diabetes, and the rising number of awareness programs that bolster the regional market growth.

    The Asia-Pacific is expected to grow at a healthy CAGR during the review period on account of increasing diabetes prevalence, obesity, favorable government initiatives to create awareness about injection techniques, and rising market penetration by key product manufacturers.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The market is highly populated with the presence of several local, regional, and global players. Most of the major players compete in some of the governing factors including price, product offerings, regional presence, etc. 

    The following are the key players in the diabetes injection pens market (arranged alphabetically).

    Note: The above list does not necessarily include all the top players in the market.

    Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept so that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Diabetes Injection Pens Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Who are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Target Audience

    The target audience of the diabetes injection pens market includes-

    • Diabetes Injection Pens Manufacturers
    • Vendors
    • Distributors
    • Organizations
    • Government Bodies.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case you need any custom research requirements related to market assessment, competitive benchmarking, sourcing and procurement, target screening, or other requirements, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Diabetic patients use diabetes injection pens to regulate insulin. It is an easy & convenient way of taking insulin doses via an injection. Diabetes injection pen aids in enhancing the quality of life and minimizes fear of hyperglycemia. The lower cost of insulin pens spurs their affordability among the different age groups of people. Diabetes pens should not be shared among others as there is a risk of transmission of diseases such as hepatitis B.

    The market is estimated to grow at a healthy CAGR of 10.80% during the forecast period.

    The following are some of the key players operating in the global diabetes injection pens market Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), BD (US), Ypsomed Holding (Switzerland), Dongbao (China), Owen Mumford (UK), Ganlee (China), Delfu (China), Biocon Ltd (India).

    The diabetes injection pens market is estimated to reach USD 6.07 billion by 2028.

    North America accounted for the highest share of the market & is expected to grow at a robust CAGR during the forecast period.

    The target audience of the Diabetes Injection Pens Market includes- Diabetes Injection Pens Vendors, Diabetes Injection Pens Manufacturers, Diabetes Injection Pens Distributors, Organizations, Government Bodies.

    The study period of this market report is 2017-2028.